IB
Universal Ibogaine Inc.
IBOGF · OTC
$0.00 N/A (+$0.00)
1M -96.09%
Market Cap $11.5M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
34 /100
Fair P/S 10.75x
P/B 2.92x
P/E N/A
Growth
100 /100
Growing Book val. growth 171.46%
EPS growth N/A
Rev. growth N/A
Profitability
50 /100
Moderate Gross margin 100.00%
Net margin 980.22%
Op. margin 46.43%
Quality
30 /100
Poor ROIC 8.70%
ROA 166.14%
Asset turnover 0.17x
Debt
73 /100
Low Debt/Equity 0.44x
Current ratio 1.60x
Int. coverage 0.00x
Stability
1 /100
Unstable Beta 4.38x
EPS volatility 105.25%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre IBOGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Nicholas Peter Karos
Employees
7
Headquarters
Calgary